Today: 25 May 2026
Visa stock today: V slips after hours after SEC filing details class B conversion-rate cut
30 December 2025
2 mins read

Visa stock today: V slips after hours after SEC filing details class B conversion-rate cut

NEW YORK, December 30, 2025, 5:24 PM ET — After-hours.

Visa Inc shares were down about 0.3% in after-hours trading on Tuesday after the payments processor disclosed in a Form 8-K — a filing used to report major events to investors — that it updated the conversion rates on its class B-1 and B-2 common stock following a $500 million deposit into its U.S. litigation escrow account. Visa said the B-1 conversion rate fell to 1.5491 from 1.5549 and the B-2 rate fell to 1.5108 from 1.5223, cutting the “as-converted” class B-2 share count by about 1.38 million and the class B-1 count by about 27,782; the filing, signed by Chief Financial Officer Chris Suh, said the adjustment has “the same effect on earnings per share as repurchasing” class A shares. SEC

The disclosure is technical, but it touches a metric investors track closely: earnings per share, or EPS, which divides profit by the number of shares. A smaller share count can lift EPS even when the business is unchanged.

It also keeps focus on litigation-related cash set-asides for the card network at year-end, when investors tend to scrutinize capital returns and non-operating items.

Visa’s class B-1 and B-2 shares, held mainly by U.S. financial institutions, convert into class A stock at a conversion rate — the number of class A shares each class B share would become. When Visa funds the litigation escrow account under its U.S. retrospective responsibility plan, the conversion rate is reduced, shifting the cost to class B holders and reducing dilution — meaning fewer shares over which profits are spread.

In Tuesday’s filing, Visa said it calculated the adjustment using a three-day volume-weighted average price, or VWAP — a price measure that weights trades by volume — for the period from Dec. 23 through Dec. 26.

Visa ended the regular session at $353.62, down 0.28% on the day and about 6% below its 52-week high of $375.51, according to the company’s investor relations stock quote page.

The move left Visa trading broadly in line with other payment-network names, including Mastercard and American Express, in subdued year-end dealings.

U.S. stocks were muted in holiday-thinned trading on Tuesday, with gains in some sectors offset by weakness in others as investors looked for fresh catalysts into the final days of the year, a Reuters report said.

Traders said lighter volumes can amplify price swings, particularly in large-cap financial stocks that often see portfolio rebalancing around month- and year-end.

Before the next regular session, investors will also keep an eye on Visa’s corporate calendar, including its annual meeting scheduled for Jan. 27, 2026, according to the company’s investor relations site.

Wall Street will also be watching for Visa’s next quarterly report in late January; Nasdaq’s earnings calendar currently lists Jan. 29, 2026 as an estimated reporting date, noting it is derived from historical patterns rather than a company announcement.

When Visa reports next, investors are likely to focus on payment volumes, cross-border activity tied to travel spending, and how litigation-related obligations interact with share repurchases and other capital returns.

For now, Tuesday’s filing did not point to a change in Visa’s operating outlook, but it underscored how legal-risk reserves can still affect per-share math — a detail that can matter when valuations are set on EPS.

Stock Market Today

  • GSK Stock Gains Appeal Post-Correction Amid Strong Q1 Results and Shareholder Returns
    May 25, 2026, 12:42 PM EDT. GlaxoSmithKline (GSK) shares show improved attractiveness following a modest price pullback. The stock's appeal is bolstered by increased dividends and ongoing share buybacks, signaling confidence in future cash flows. Solid first-quarter 2026 earnings further strengthen the outlook, reflecting operational resilience. Additionally, robust deal activity adds to growth prospects, supporting investment interest. These combined factors position GSK as a potentially compelling opportunity for investors seeking stable returns and growth in the pharmaceutical sector.

Latest articles

HIVE Rises Ahead of Memorial Day Test

HIVE Rises Ahead of Memorial Day Test

25 May 2026
HIVE Digital Technologies shares surged 51% on Nasdaq last week, closing Friday at $4.07 after announcing plans for a C$3.5 billion AI data center near Toronto. Cantor Fitzgerald raised its price target to $4.60. U.S. markets are closed Monday for Memorial Day; HIVE traded near C$5.78 on the Toronto Stock Exchange. The planned facility would use over 100,000 GPUs and is set to open in 2027.
Baytex Drops After Oil Falls 5% in 2026 Rout

Baytex Drops After Oil Falls 5% in 2026 Rout

25 May 2026
Baytex Energy shares fell 3.7% to C$6.86 on the Toronto Stock Exchange Monday, tracking a 2.1% drop in the S&P/TSX energy sector as oil prices slumped. Brent crude lost 4.8% to $98.57 a barrel amid speculation of a U.S.-Iran deal reopening the Strait of Hormuz. U.S. markets were closed for Memorial Day, leaving Baytex trading only in Toronto. The stock is down 6% in four weeks but up 200% over the past year.
Wendy’s turnaround now extends beyond burger discounts

Wendy’s turnaround now extends beyond burger discounts

25 May 2026
Wendy’s U.S. same-restaurant sales fell 7.8% in Q1 after an 11.3% drop in Q4, prompting Zacks Research to lower its Q2 earnings forecast to 17 cents per share. Robert Wright took over as CEO on May 21 as the chain closed 164 U.S. stores and faces pressure from activist investor Nelson Peltz. Shares last traded at $7.81 before the Memorial Day market closure.
Goldman Sachs stock slips after Fed minutes — here’s what traders are watching next
Previous Story

Goldman Sachs stock slips after Fed minutes — here’s what traders are watching next

IonQ stock steadies after South Korea 100-qubit Tempo deal as traders eye $45 level
Next Story

IonQ stock steadies after South Korea 100-qubit Tempo deal as traders eye $45 level

Go toTop